Clinical Trials Browser

INDUSTRY × R-CHOP protocol × Lymphoid × Clear all

NCT06549595 2026-03-18

A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients

Phase 3 Recruiting

Lymphoma, Follicular

NCT04542824 2026-03-03

EPCORE™ NHL-3

Phase 1/2 Active not recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone

NCT04663347 2026-03-03

EPCORE™ NHL-2

Phase 1/2 Active not recruiting

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT05888493 2026-02-20

LEDA

Phase 3 Active not recruiting

Lymphoma, Follicular, Recurrence

NCT04661007 2025-12-18

J-MIND

Phase 1/2 Active not recruiting

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT00268853 2024-05-30

RAPID

Phase 2 Completed

124 enrolled 13 charts

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT03650933 2024-02-20

A Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma Patients

Phase 3 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT02605694 2021-03-17

Duvelisib With Rituximab vs R-CHOP in Subjects With Relapsed/Refractory Follicular Lymphoma (FRESCO)

Phase 2 Withdrawn

Lymphoma